Zydus Corporate Rivalry: As Roche blocks Zydus’ Pertuzumab launch, experts see murky corporate rivalry, ET HealthWorld
Mumbai: Sigrima, Zydus Lifesciences’ biosimilar challenge to Roche’s breast cancer blockbuster brand Perjeta is swirling into controversies. After a recent injunction against its launch from the Delhi High Court ...
